Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3159977rdf:typepubmed:Citationlld:pubmed
pubmed-article:3159977lifeskim:mentionsumls-concept:C0036751lld:lifeskim
pubmed-article:3159977lifeskim:mentionsumls-concept:C0039082lld:lifeskim
pubmed-article:3159977lifeskim:mentionsumls-concept:C0678226lld:lifeskim
pubmed-article:3159977lifeskim:mentionsumls-concept:C0949469lld:lifeskim
pubmed-article:3159977lifeskim:mentionsumls-concept:C0127400lld:lifeskim
pubmed-article:3159977pubmed:issue3lld:pubmed
pubmed-article:3159977pubmed:dateCreated1985-8-12lld:pubmed
pubmed-article:3159977pubmed:abstractTextThe 5-hydroxytryptamine (5-HT) uptake inhibitor, paroxetine (11.6 mg/kg i.p.), given to rats pretreated with the monoamine oxidase inhibitor, phenelzine, 18 h (46.8 mg/kg i.p.) and 90 min (11.7 mg/kg i.p.) before, evoked a 5-HT-dependent syndrome which included wet-dog shakes (WDS). The frequency of WDS declined over the ensuing 3 h, at which time cortical 5-HT2 receptors showed a significant (30%) decrease in number. A second injection of paroxetine given at this time did not evoke a significant increase in the number of WDS, suggesting that spinal 5HT2 receptors might also have been down-regulated at the same time.lld:pubmed
pubmed-article:3159977pubmed:languageenglld:pubmed
pubmed-article:3159977pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3159977pubmed:citationSubsetIMlld:pubmed
pubmed-article:3159977pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3159977pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3159977pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3159977pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3159977pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3159977pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3159977pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3159977pubmed:statusMEDLINElld:pubmed
pubmed-article:3159977pubmed:monthAprlld:pubmed
pubmed-article:3159977pubmed:issn0304-3940lld:pubmed
pubmed-article:3159977pubmed:authorpubmed-author:SmokcumR WRWlld:pubmed
pubmed-article:3159977pubmed:authorpubmed-author:StephensonJ...lld:pubmed
pubmed-article:3159977pubmed:authorpubmed-author:KoshikawaNNlld:pubmed
pubmed-article:3159977pubmed:issnTypePrintlld:pubmed
pubmed-article:3159977pubmed:day19lld:pubmed
pubmed-article:3159977pubmed:volume55lld:pubmed
pubmed-article:3159977pubmed:ownerNLMlld:pubmed
pubmed-article:3159977pubmed:authorsCompleteYlld:pubmed
pubmed-article:3159977pubmed:pagination279-82lld:pubmed
pubmed-article:3159977pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3159977pubmed:meshHeadingpubmed-meshheading:3159977-...lld:pubmed
pubmed-article:3159977pubmed:meshHeadingpubmed-meshheading:3159977-...lld:pubmed
pubmed-article:3159977pubmed:meshHeadingpubmed-meshheading:3159977-...lld:pubmed
pubmed-article:3159977pubmed:meshHeadingpubmed-meshheading:3159977-...lld:pubmed
pubmed-article:3159977pubmed:meshHeadingpubmed-meshheading:3159977-...lld:pubmed
pubmed-article:3159977pubmed:meshHeadingpubmed-meshheading:3159977-...lld:pubmed
pubmed-article:3159977pubmed:meshHeadingpubmed-meshheading:3159977-...lld:pubmed
pubmed-article:3159977pubmed:meshHeadingpubmed-meshheading:3159977-...lld:pubmed
pubmed-article:3159977pubmed:meshHeadingpubmed-meshheading:3159977-...lld:pubmed
pubmed-article:3159977pubmed:meshHeadingpubmed-meshheading:3159977-...lld:pubmed
pubmed-article:3159977pubmed:meshHeadingpubmed-meshheading:3159977-...lld:pubmed
pubmed-article:3159977pubmed:meshHeadingpubmed-meshheading:3159977-...lld:pubmed
pubmed-article:3159977pubmed:meshHeadingpubmed-meshheading:3159977-...lld:pubmed
pubmed-article:3159977pubmed:meshHeadingpubmed-meshheading:3159977-...lld:pubmed
pubmed-article:3159977pubmed:meshHeadingpubmed-meshheading:3159977-...lld:pubmed
pubmed-article:3159977pubmed:year1985lld:pubmed
pubmed-article:3159977pubmed:articleTitleIs waning of a 5-hydroxytryptamine (5-HT)-mediated syndrome due to 5-HT2 receptor down-regulation?lld:pubmed
pubmed-article:3159977pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3159977pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3159977lld:pubmed